SCHEMBL31267853

SCHEMBL31267853

COC(=O)c1cc(Br)nc(Cl)c1C

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
ALDH1A1 P00352 3/20 0.40
ABL1 P00519 1/20 0.39
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NQO2 P16083 4/20 0.38
RXFP1 Q9HBX9 1/20 0.38
GAA P10253 2/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12701205 0.83 KDM4E (0.54) L3MBTL1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL29592465 0.83 KDM4E (0.54) L3MBTL1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL5203594 0.83 L3MBTL1 (0.43) L3MBTL1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL26040458 0.82 NQO2 (0.46) L3MBTL1KDM4EMAPTALDH1A1ABL1
SCHEMBL29845480 0.81 ALDH1A1 (0.42) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL16761769 0.80 KDM4E (0.49) L3MBTL1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL30700987 0.80 L3MBTL1 (0.39) L3MBTL1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL5249944 0.78 KDM4E (0.39) L3MBTL1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL22717309 0.76 SMN1; SMN2 (0.45) L3MBTL1KDM4ESMN1; SMN2MAPTNPC1
SCHEMBL16336369 0.75 ABL1 (0.45) L3MBTL1KDM4ESMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724441-A1 ISOINDOLINONE AND DIHYDROPYRROLOPRIDINONE COMPOUNDS AND USES THEREOF Revir Therapeutics, Inc. (US) 2026-04-15 EP disclosed
WO-2024251212-A1 ISOINDOLINONE AND DIHYDROPYRROLOPRIDINONE COMPOUNDS AND USES THEREOF REVIR THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed
WO-2024251211-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR MODULATING SPLICING OF MSH3 REVIR THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed